AIPL Announces Premier Opthalmic Pathology Consultation Group

SILVER SPRING, Md.--(BUSINESS WIRE)--American International Pathology Laboratories™ (AIPL™) announces the formation of the first ever multi-subspecialty group to diagnose Opthalmic Pathology cases. With the small number of Opthalmic Pathologists in the United States, the need exists for a comprehensive group to render expert diagnostic opinions on cases involving the eye.

The team will focus on all types of Opthalmic Pathology cases, including temporal arteritis, melanoma, epithelial, hematologic and soft tissue tumors of the eye, lacrimal gland pathology, eyelid skin and mucosal lesions, retinal and macular pathology, corneal diseases, infections of the eye and orbital bony lesions.

The expert group consists of Rudy J. Castellani, M.D., Aaron Auerbach, M.D., M.P.H., Julie C. Fanburg-Smith, M.D., Allen P. Burke, M.D., Fabio R. Tavora, M.D., Magda Tomaszewski, M.D., Gary R. Warnock, D.D.S, M.S., M.A., Jacqueline A. Wieneke, M.D. and Ron Neafie, M.S. Drawing on their years of experience and their centralized location in Silver Spring, MD, this team is able to bring a collaborative approach and their combined expertise to the most complex Opthalmic Pathology cases, leading to the best possible patient care.

In addition, this group has also published extensively on vascular, soft tissue, maxillofacial, head and neck, helminthes, fungi, bacteria, protozoa, arthopods and other areas of Ophthalmic Tumors and Pathology. Pathologists from this group also teach regularly about vasculitis at the American College of Rheumatologists.

For more information about this premier team and AIPL, please visit http://aiplaboratories.com or call 1-877-234-7522.

About American International Pathology Laboratories (AIPL)

AIPL is a specialty anatomic pathology laboratory focused on providing premium services in both primary and second opinions, covering every organ in the human body. AIPL combines the hundreds of years of expertise of its pathologists with fast turn-around time, third-party billing and state of the art information technology and laboratory studies. AIPL also offers the latest technology in virtual pathology and immunohistochemistry.